2011•China Medical HeraldRequires access

Clinical observation of bronchial asthma treated by Montelukast

Zhang Hu

Abstract

Objective: To observe the long-term therapeutic effect of Montelukast on bronchial asthma.Methods: Forty patients with bronchial asthma were enrolled and divided into treatment group and control group randomly.The patients in control group were treated with inhaled corticosteroid(ICS)(10 mg/d) and long acting β2-agonist(LABA),and those in treatment group were added Montelukast.Both of the groups were inhaled short-acting β2-agonists and given oxygen therapy.Results: The effective rate of treatment group was higher than that of control group(90.0% vs 85.0%,P0.05).Conclusion: Montelukast is an effective and safe treatment method to bronchial asthma and worthy to clinical application.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, Montelukast, Asthma, Anesthesia, Corticosteroid, Agonist, Internal medicine, Receptor